Original BioMedicals Co., Ltd.
6483
Rank in Stocks
#24774
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating... Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
Share Price
$0.4587911
Last synced: 2026-11-10
Market Cap
$30.65M
Change (1 day)
2.03%
Change (1 year)
37.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Original BioMedicals Co., Ltd. (6483)
Category
Healthcare
Operating Margin for Original BioMedicals Co., Ltd. (6483)
Operating Margin as of November 2026 TTM: 0.00%
According to Original BioMedicals Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of -27,453.02%.
Operating Margin history for Original BioMedicals Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2025 | -27,453.02% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | -137,818.60% | 267.05% |
| 2022 | -37,547.66% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | - |
DE
|
|
| 19.68% | - |
DE
|
|
| 13.26% | - |
JP
|
|
| 17.08% | - |
CH
|
|
| 14.92% | - |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Original BioMedicals Co., Ltd.'s operating margin
What was Original BioMedicals Co., Ltd.'s operating margin in 2025?
In 2025, Original BioMedicals Co., Ltd.'s operating margin was -27,453.02%, compared with 0.00% in 2024.
How has Original BioMedicals Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Original BioMedicals Co., Ltd.'s operating margin was highest in 2024 (0.00%) and lowest in 2023 (-137,818.60%).
How does Original BioMedicals Co., Ltd.'s operating margin compare with similar companies?
Original BioMedicals Co., Ltd.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.